Approved PLCO Projects
Here you can browse the complete list of projects for PLCO whose requests for data/biospecimens were approved.
| Name | Principal Investigator | Institution | Study | Date Approved | Project ID |
|---|---|---|---|---|---|
| Use of Breast Cancer Risk Reducing Medications | Paul Pinsky | National Institutes of Health | PLCO | Nov 19, 2024 | PLCO-1749 |
| Detection of lung disease using deep learning | Himanshu Joshi | Drongo AI pvt LTD | PLCO | Nov 15, 2024 | PLCOI-1747 |
| Exploring the Association Between Environmental and Genetic Factors with All-Cause Mortality Using the PLCO Database | Fulan Hu | Shenzhen University Medical School | PLCO | Nov 12, 2024 | PLCO-1666 |
| Development and validation of a prediction model for colorectal cancer prognosis | Ching Wai Krista Chung | The University of Hong Kong | PLCO | Nov 12, 2024 | PLCO-1741 |
| The correlation between Fat Quality Index and the risk of upper gastrointestinal cancer in the American population: a prospective cohort study | Yi Xiao | The Second Affiliated Hospital of Chongqing Medical University | PLCO | Nov 7, 2024 | PLCO-1733 |
| Body fat distribution and risk of colorectal cancer in the PLCO cohort | Shun Zhang | Shanghai East Hospital, School of Medicine, Tongji University | PLCO | Nov 7, 2024 | PLCO-1736 |
| Analysis of Chest X-rays Based on Deep Learning for Health Risk Assessment | Yu Fei Huang | China Medical University | PLCO | Nov 5, 2024 | PLCOI-1730 |
| Association Between Protein Diet Score And Colorectal Adenoma Risk: A Prospective Study | Haitao Gu | The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. | PLCO | Nov 5, 2024 | PLCO-1724 |
| Pan-cancer analysis of inflammatory diet, tumor immune infiltration, and survival | QianXue Wu | Chongqing Medical University | PLCO | Nov 5, 2024 | PLCOI-1718 |
| The growing incidence of of colorectal cancer among those under 55 years age in The United States | Harrinique Deveaux | Florida State University | PLCO | Nov 5, 2024 | PLCO-1727 |
| Surrogate endpoints for cancer screening trials | Adam Brentnall | Queen Mary University of London | PLCO | Nov 5, 2024 | PLCO-1719 |
| An explainable liver disease screening-based machine learning model | Angélica Atehortúa | ISGlobal Barcelona Institute for Global Health | PLCO | Oct 17, 2024 | PLCO-1712 |
| AI-based Pan-Cancer Survival Outcome Prediction and Biomarker Discovery | Jana Lipkova | University of California, Irvine | PLCO | Oct 17, 2024 | PLCOI-1715 |
| From physiology to pathology | Gabriela Epihova | University of Cambridge | PLCO | Oct 16, 2024 | PLCO-1711 |
| Harnessing TME depicted by histological images to improve lung cancer prognosis through a deep learning system | Ruiyi Yang | China Medical University | PLCO | Oct 16, 2024 | PLCOI-1709 |
| BMI trajectory and the risk of endometrial cancer | Yuanjian Wang | Department of Obstetrics and Gynecology, Qilu Hospital of Shandong University | PLCO | Oct 16, 2024 | PLCO-1707 |
| Anti-inflammatory diet and tumor microenvironment during colorectal carcinogenesis | QianXue Wu | Chongqing Medical University | PLCO | Oct 11, 2024 | PLCOI-1691 |
| Evaluating risk factor-based strategies for oversampling of individuals at higher risk of cancer for bioscpecimen collection and prospective assessment of Multi-Cancer Detection assays | Filip Pirsl | National Cancer Institute | PLCO | Oct 11, 2024 | PLCO-1704 |
| Combine genetic, pathologic, and lifestyle factors for pan-cancer survival assessment | Rong Zhong | Huazhong University of Science and Technology | PLCO | Oct 11, 2024 | PLCO-1701 |
| Fairness of AI use in Healthcare | Stacy Amadi | Northwestern University School of Professional Studies | PLCO | Oct 11, 2024 | PLCO-1696 |